000 | 01102 a2200337 4500 | ||
---|---|---|---|
005 | 20250511184545.0 | ||
264 | 0 | _c19930106 | |
008 | 199301s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/0006-8993(92)91326-a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAltemus, M | |
245 | 0 | 0 |
_aChronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro. _h[electronic resource] |
260 |
_bBrain research _cOct 1992 |
||
300 |
_a311-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine Vasopressin _xmetabolism |
650 | 0 | 4 |
_aDesipramine _xpharmacology |
650 | 0 | 4 |
_aFluoxetine _xpharmacology |
650 | 0 | 4 |
_aHypothalamus _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 |
_aTrazodone _xpharmacology |
700 | 1 | _aCizza, G | |
700 | 1 | _aGold, P W | |
773 | 0 |
_tBrain research _gvol. 593 _gno. 2 _gp. 311-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-8993(92)91326-a _zAvailable from publisher's website |
999 |
_c1457427 _d1457427 |